Speakers in this community conversations program review hot topics in obesity medicine and how they relate to hepatology. Topics addressed include nutrition, bariatric surgery, and endoscopy, and how each relates to obesity medicine and liver disease. A successful program that employs a multidisciplinary approach in applying obesity medicine treatment with consideration of the patient with chronic liver disease is reviewed. Presenters also discuss the new glucagon-like peptide-1 (GLP-1) receptor agonist medications, their efficacy, and the science behind the buzz.